Capricor Therapeutics Inc (NASDAQ:CAPR) has a beta value of 3.95 and has seen 0.43 million shares traded in the recent trading session. The company, currently valued at $222.00M, closed the recent trade at $7.07 per share which meant it gained $0.31 on the day or 4.59% during that session. The CAPR stock price is -16.27% off its 52-week high price of $8.22 and 62.09% above the 52-week low of $2.68. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.4 million shares traded. The 3-month trading volume is 249.41K shares.
Capricor Therapeutics Inc (NASDAQ:CAPR) trade information
Sporting 4.59% in the green today, the stock has traded in the green over the last five days, when the CAPR stock price touched $7.07 or saw a rise of 1.53%. Year-to-date, Capricor Therapeutics Inc shares have moved 44.58%, while the 5-day performance has seen it change 19.83%. Over the past 30 days, the shares of Capricor Therapeutics Inc (NASDAQ:CAPR) have changed 95.84%. Short interest in the company has seen 2.7 million shares shorted with days to cover at 16.22.
Capricor Therapeutics Inc (CAPR) estimates and forecasts
Figures show that Capricor Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 14.03% over the past 6 months, with this year growth rate of 0.00%, compared to 18.50% for the industry. Revenue growth from the last financial year stood is estimated to be 13.30%.
3 analysts offering their estimates for the company have set an average revenue estimate of $9.7 million for the current quarter. 3 have an estimated revenue figure of $4.41 million for the next quarter concluding in Jun 2024. Year-ago sales stood $2.99 million and $3.92 million respectively for this quarter and the next, and analysts expect sales will grow by 224.80% for the current quarter and 12.60% for the next.
CAPR Dividends
Capricor Therapeutics Inc is expected to release its next earnings report between May 09 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Capricor Therapeutics Inc (NASDAQ:CAPR)’s Major holders
Insiders own 9.19% of the company shares, while shares held by institutions stand at 21.69% with a share float percentage of 23.89%. Investors are also buoyed by the number of investors in a company, with Capricor Therapeutics Inc having a total of 47 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 1.15 million shares worth more than $5.48 million. As of Jun 29, 2023, Vanguard Group Inc held 4.45% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 0.41 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $1.96 million and represent 1.59% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2023, the former fund manager holds about 2.98% shares in the company for having 0.77 million shares of worth $3.67 million while later fund manager owns 0.34 million shares of worth $1.6 million as of Jun 29, 2023, which makes it owner of about 1.30% of company’s outstanding stock.
